We are live on ! Find out more
LBA

Lowell Blake & Associates Portfolio holdings

AUM $355M
1-Year Est. Return 33.69%
This Fund
S&P 500
This Quarter Est. Return
-4.96%
1 Year Est. Return
+33.69%
3 Year Est. Return
+44.18%
5 Year Est. Return
10 Year Est. Return
AUM
$265M
AUM Growth
+$10.5M
Cap. Flow
+$25.6M
Cap. Flow %
9.67%
Top 10 Hldgs %
52.35%
Holding
57
New
2
Increased
35
Reduced
7
Closed
1

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$2.3M
2
AAPL icon
Apple
AAPL
+$2.22M
3
NVDA icon
NVIDIA
NVDA
+$2.12M
4
PG icon
Procter & Gamble
PG
+$1.97M
5
HD icon
Home Depot
HD
+$1.48M

Top Sells

Rank Stock Value
1
UL icon
Unilever
UL
+$740K
2
MSGS icon
Madison Square Garden
MSGS
+$410K
3
MMM icon
3M
MMM
+$389K
4
RTX icon
RTX Corp
RTX
+$352K
5
INTC icon
Intel
INTC
+$300K

Sector Composition

Rank Sector Weight
1 Technology 27.07%
2 Healthcare 17.34%
3 Consumer Staples 14.09%
4 Consumer Discretionary 12.94%
5 Industrials 10.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COP icon
26
ConocoPhillips
COP
$147B
$3.51M 1.32%
35,089
+1,255
+4% +$115K
ECL icon
27
Ecolab
ECL
$78.1B
$3.22M 1.21%
18,213
+4,699
+35% +$883K
JJSF icon
28
J&J Snack Foods
JJSF
$1.43B
$3.16M 1.19%
20,356
+1,409
+7% +$219K
GOOG icon
29
Alphabet (Google) Class C
GOOG
$4.36T
$3.01M 1.14%
21,580
+1,620
+8% +$220K
MTD icon
30
Mettler-Toledo International
MTD
$28.6B
$2.75M 1.04%
2,000
+62
+3% +$89.5K
MSGS icon
31
Madison Square Garden
MSGS
$9.48B
$1.92M 0.73%
10,729
-2,408
-18% -$410K
IPGP icon
32
IPG Photonics
IPGP
$3.61B
$1.91M 0.72%
17,371
+1,200
+7% +$165K
NVO
33
Novo Nordisk
NVO
$208B
$1.52M 0.57%
27,454
+3,580
+15% +$184K
ORCL icon
34
Oracle
ORCL
$374B
$1.24M 0.47%
15,000
GPC icon
35
Genuine Parts
GPC
$17.1B
$985K 0.37%
7,820
INTC icon
36
Intel
INTC
$455B
$962K 0.36%
19,412
-6,045
-24% -$300K
IVV icon
37
iShares Core S&P 500 ETF
IVV
$878B
$732K 0.28%
1,614
+56
+4% +$25K
SON icon
38
Sonoco
SON
$5.57B
$726K 0.27%
11,600
ROL icon
39
Rollins
ROL
$18.3B
$609K 0.23%
17,363
-110
-0.6% -$3.57K
MMM icon
40
3M
MMM
$90.9B
$585K 0.22%
4,697
-2,922
-38% -$389K
BRK.B icon
41
Berkshire Hathaway Class B
BRK.B
$1.1T
$531K 0.2%
1,504
+8
+0.5% +$2.59K
VO icon
42
Vanguard Morningstar Mid-Cap ETF
VO
$106B
$455K 0.17%
7,652
AZO icon
43
AutoZone
AZO
$49.2B
$429K 0.16%
+210
New +$410K
TMO icon
44
Thermo Fisher Scientific
TMO
$213B
$428K 0.16%
725
FUTY icon
45
Fidelity MSCI Utilities Index ETF
FUTY
$2.31B
$400K 0.15%
8,342
MTUM icon
46
iShares MSCI USA Momentum Factor ETF
MTUM
$25B
$371K 0.14%
2,205
NEE icon
47
NextEra Energy
NEE
$181B
$328K 0.12%
3,875
+1,328
+52% +$106K
SCHM icon
48
Schwab US Mid-Cap ETF
SCHM
$14.5B
$304K 0.11%
12,003
COST icon
49
Costco
COST
$422B
$302K 0.11%
525
WIRE
50
DELISTED
Encore Wire Corp
WIRE
$250K 0.09%
2,189
-100
-4% -$12K

Similar funds

Lowell Blake & Associates's Q1 2022 Portfolio in Review

As of Q1 2022, Lowell Blake & Associates held 57 positions worth $265M, up 4.1% from $255M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Lowell Blake & Associates deployed $25.6M of net new capital in Q1 2022, opening 2 new positions and adding to 35 existing holdings. Its largest new stake was AutoZone: 210 shares worth $429K.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was Unilever, an estimated $740K trimmed.

  • Lowell Blake & Associates's largest Q1 2022 buy was AutoZone: 210 shares worth $429K.
  • Lowell Blake & Associates added most to Microsoft in Q1 2022, an estimated $2.3M increase.
  • Lowell Blake & Associates's biggest Q1 2022 reduction was Unilever, cutting an estimated $740K.
  • Lowell Blake & Associates fully exited RTX Corp in Q1 2022, selling an estimated $352K.
  • Lowell Blake & Associates's ten largest holdings make up 52% of its $265M portfolio in Q1 2022.
  • Lowell Blake & Associates opened 2 new positions and closed 1 in Q1 2022.
  • Lowell Blake & Associates's portfolio value rose 4.1% quarter-over-quarter to $265M.

Based on Lowell Blake & Associates's 13F filing for Q1 2022, filed 13 May 2022.